Articles related to PHARMACY OPERATIONS & MGMT

Prescription digital therapeutics (PDTs) are a rapidly growing area of healthcare. As a pharmacist, you should be aware of the potential benefits and risks of PDTs for your patients.

Explore the DEA’s latest regulations on electronic prescriptions for controlled substances, a significant step towards modernizing pharmacy practices. Learn more about how these changes may impact the way prescriptions are transferred and managed, aligning with current technological advancements and legal requirements.

The application of NIOSH Hazardous Drug Assessment principles to home healthcare is a critical development in ensuring safety. As home delivery of treatments like chemotherapy grows, understanding and implementing these principles become vital for healthcare professionals, patients, and their families. Explore how these principles are being adapted to protect all involved in this complex process.

The recent study exploring the Mark Cuban Cost Plus Drug Company’s potential impact on Medicare’s oncology drug spending uncovers significant savings opportunities. Physicians may find interest in this model’s potential to improve access to essential cancer medications through reduced costs, emphasizing a call to examine current overpayment within the Medicare system.

This study demonstrates how pharmacists can improve patient safety and dramatically save costs in the management of chronic myeloid leukemia by highlighting the possibility of pharmacist-led TKI cessation programs.

Unpacking the landmark summit led by the American Pharmacists Association, it becomes clear that there is a pressing need and opportunity to expand healthcare coverage for pharmacists’ patient care services, promising substantial impacts on patient care and health systems.